0.03 (-21.59%)
As of Nov 09, 2023
Source:
Calithera Biosciences, Inc is a fully-integrated, clinical stage precision oncology biopharmaceutical company. On January 9, 2023, we announced, after extensive consideration of potential strategic alternatives, that our Board of Directors had unanimously approved the dissolution and liquidation of Calithera pursuant to a plan of complete liquidation and dissolution, or the Plan of Dissolution, subject to stockholder approval.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | 650-870-1000 |
Industry | manufacturing |
CEO | Susan M. Molineaux |
Website | calithera.com |